Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
. (2010) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 45:3, pages 259-260.
Read now
Read now
Articles from other publishers (27)
Fengping Li, Andrea T. Hooper, Jonathon Golas, Chao-Pei Betty Chang, Hendrik Neubert & Lindsay King. (2022) Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS. Journal of Proteome Research 21:10, pages 2331-2340.
Crossref
Crossref
Habibie Habibie, Adhyatmika Adhyatmika, Dedmer Schaafsma & Barbro N. Melgert. (2021) The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases. Pharmacology & Therapeutics 228, pages 107941.
Crossref
Crossref
Hiba Ghura, Marin Keimer, Anja von Au, Norman Hackl, Verena Klemis & Inaam A. Nakchbandi. (2021) Inhibition of fibronectin accumulation suppresses tumor growth. Neoplasia 23:9, pages 837-850.
Crossref
Crossref
Emma Reungoat, Boyan Grigorov, Fabien Zoulim & Eve-Isabelle Pécheur. (2021) Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers 13:9, pages 2270.
Crossref
Crossref
Sami A. Gabr & Ahmad H. Alghadir. (2021) Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients. Disease Markers 2021, pages 1-13.
Crossref
Crossref
Franziska Wirth, Alexander Lubosch, Stefan Hamelmann & Inaam A. Nakchbandi. (2020) Fibronectin and Its Receptors in Hematopoiesis. Cells 9:12, pages 2717.
Crossref
Crossref
Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Masahiro Ogawa, Shunichi Matsuoka, Seth J. Karp & Mitsuhiko Moriyama. (2020) Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives. International Journal of Molecular Sciences 21:14, pages 4906.
Crossref
Crossref
Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Hui-Fang Yang, Chen-Jung Wu, Yu-Shan Sun & Wei-Liang Chen. (2019) Crosssectional Assessment of Bone Mass Density in Adults with Hepatitis B Virus and Hepatitis C Virus Infection. Scientific Reports 9:1.
Crossref
Crossref
Verena Klemis, Hiba Ghura, Giuseppina Federico, Carina Würfel, Anke Bentmann, Norbert Gretz, Tatsuhiko Miyazaki, Hermann-Joseph Gröne & Inaam A. Nakchbandi. (2017) Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney International 91:6, pages 1374-1385.
Crossref
Crossref
Carla Sens, Katrin Huck, Stefan Pettera, Stephan Uebel, Guido Wabnitz, Markus Moser & Inaam A. Nakchbandi. (2017) Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins. Journal of Biological Chemistry 292:19, pages 7745-7760.
Crossref
Crossref
Yin-Ying Lu, Xue-Ke Zhao, Lei Yu, Fei Qi, Bing Zhai, Chang-Qing Gao & Qiang Ding. (2017) Interaction of Src and Alpha-V Integrin Regulates Fibroblast Migration and Modulates Lung Fibrosis in A Preclinical Model of Lung Fibrosis. Scientific Reports 7:1.
Crossref
Crossref
Lei He, Fa-hu Yuan, Ting Chen, Qiang Huang, Yu Wang & Zhi-guo Liu. (2017) ER stress-mediated cell damage contributes to the release of EDA+ fibronectin from hepatocytes in nonalcoholic fatty liver disease. Journal of Huazhong University of Science and Technology [Medical Sciences] 37:2, pages 217-225.
Crossref
Crossref
Carla Sens, Eva Altrock, Katrin Rau, Verena Klemis, Anja von Au, Stefan Pettera, Stephan Uebel, Timo Damm, Sanjay Tiwari, Markus Moser & Inaam A Nakchbandi. (2017) An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin. Journal of Bone and Mineral Research 32:1, pages 70-81.
Crossref
Crossref
Stephanie Rossnagl, Eva Altrock, Carla Sens, Sabrina Kraft, Katrin Rau, Michael D. Milsom, Thomas Giese, Yvonne Samstag & Inaam A. Nakchbandi. (2016) EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLOS Biology 14:9, pages e1002562.
Crossref
Crossref
M. Guarino, I. Loperto, S. Camera, V. Cossiga, C. Di Somma, A. Colao, N. Caporaso & F. Morisco. (2016) Osteoporosis across chronic liver disease. Osteoporosis International 27:6, pages 1967-1977.
Crossref
Crossref
Sabrina Kraft, Verena Klemis, Carla Sens, Thorsten Lenhard, Christian Jacobi, Yvonne Samstag, Guido Wabnitz, Michael Kirschfink, Reinhard Wallich, G. Maria Hänsch & Inaam A. Nakchbandi. (2015) Identification and characterization of a unique role for EDB fibronectin in phagocytosis. Journal of Molecular Medicine 94:5, pages 567-581.
Crossref
Crossref
Heena Kumra & Dieter P. Reinhardt. (2016) Fibronectin-targeted drug delivery in cancer. Advanced Drug Delivery Reviews 97, pages 101-110.
Crossref
Crossref
Xue-Ke Zhao, Yiju Cheng, Ming Liang Cheng, Lei Yu, Mao Mu, Hong Li, Yang Liu, Baofang Zhang, Yumei Yao, Hui Guo, Rong Wang & Quan Zhang. (2016) Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis. Scientific Reports 6:1.
Crossref
Crossref
Yiyi Chen, Zhexin Shao, Zhou Yin & Zhuxiu Jiang. (2015) Fibronectin predicts the outcome of acute-on-chronic hepatitis B liver failure. International Health 7:1, pages 67-72.
Crossref
Crossref
Swati BhattacharyyaZenshiro TamakiWenxia WangMonique HinchcliffPaul HooverSpiro GetsiosEric S. WhiteJohn Varga. (2014)
Fibronectin
EDA
Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
. Science Translational Medicine 6:232.
Crossref
Crossref
Matthäus Vasel, Renate Rutz, Claus Bersch, Peter Feick, Manfred V. Singer, Michael Kirschfink & Inaam A. Nakchbandi. (2014) Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C. Clinical Immunology 150:2, pages 149-156.
Crossref
Crossref
Anja von Au, Matthaeus Vasel, Sabrina Kraft, Carla Sens, Norman Hackl, Alexander Marx, Philipp Stroebel, Jörg Hennenlotter, Tilman Todenhöfer, Arnulf Stenzl, Sarah Schott, Hans-Peter Sinn, Antoinette Wetterwald, Justo Lorenzo Bermejo, Marco G Cecchini & Inaam A Nakchbandi. (2013) Circulating Fibronectin Controls Tumor Growth. Neoplasia 15:8, pages 925-IN24.
Crossref
Crossref
April M. Chow, Mingqian Tan, Darwin S. Gao, Shu Juan Fan, Jerry S. Cheung, Zhongwei Qiao, Kwan Man, Zheng-Rong Lu & Ed X. Wu. (2013) Molecular MRI of Liver Fibrosis by a Peptide-Targeted Contrast Agent in an Experimental Mouse Model. Investigative Radiology 48:1, pages 46-54.
Crossref
Crossref
Abdelfattah M. Attallah, Sanaa O. Abdallah, Ahmed A. Attallah, Mohamed M. Omran, Khaled Farid, Wesam A. Nasif, Gamal E. Shiha, Abdel-Aziz F. Abdel-Aziz, Nancy Rasafy & Yehia M. Shaker. (2013) Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients. Annals of Hepatology 12:1, pages 44-53.
Crossref
Crossref
Jefferson J. Doyle, Elizabeth E. Gerber & Harry C. Dietz. (2012) Matrix-dependent perturbation of TGFβ signaling and disease. FEBS Letters 586:14, pages 2003-2015.
Crossref
Crossref
Nina Kawelke, Matthaeus Vasel, Carla Sens, Anja von Au, Steven Dooley & Inaam A. Nakchbandi. (2011) Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-β. PLoS ONE 6:11, pages e28181.
Crossref
Crossref
Katharina Frey, Andjelija Zivanovic, Kathrin Schwager & Dario Neri. (2011) Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integrative Biology 3:4, pages 468-478.
Crossref
Crossref